HF
NRXP icon

HRT Financial’s NRX Pharmaceuticals NRXP Stock Holding History

HRT Financial’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$411K Buy
+100,724
New +$333K ﹤0.01% 2843
2023
Q1 		– Sell
-2,650
Closed -$29K – 2965
2022
Q4 		$29K Buy
+2,650
New +$26.7K ﹤0.01% 2148
2021
Q1 		– Sell
-1,181
Closed -$288K – 3007
2020
Q4 		$288K Buy
+1,181
New +$194K 0.01% 1311

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HRT Financial's NRXP Position: Q2 2026 in Review

HRT Financial opened a new position in NRX Pharmaceuticals (NRXP) in Q2 2026: 100,724 shares worth $411K. The stake represents ﹤0.01% of the portfolio and ranks #2843 among its holdings. This is a return to the name: HRT Financial previously reported a position in NRXP as recently as Q4 2022.

HRT Financial first reported a position in NRXP in Q4 2020 and has held it in 3 quarters since. 47 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • HRT Financial held 100,724 shares of NRX Pharmaceuticals worth $411K as of Q2 2026.
  • NRX Pharmaceuticals was a new HRT Financial position in Q2 2026.
  • NRX Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2843 holding.
  • HRT Financial first reported a position in NRX Pharmaceuticals in Q4 2020 and has held it in 3 quarters since.
  • 47 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.